Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Berger

Showing results (151-160 of 277) with videos related to

Pageof 28
Sort By:
Cardiology in the Young|December 21, 2016
Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registryTilman Humpl, Rolf M F Berger, Eric D Austin, et al.
Pulmonary Circulation|July 14, 2022
Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activationEmmanouil Mavrogiannis, Quint A J Hagdorn, Venetia Bazioti, et al.
Pharmacogenomics|June 23, 2017
Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics studyAizati N A Daud, Jorieke E H Bergman, Wilhelmina S Kerstjens-Frederikse, et al.
European Journal of Pediatrics|January 12, 2022
Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER studyAnouk Pels, Wes Onland, Rolf M F Berger, et al.
European Journal of Pediatrics|November 18, 2024
Diagnostic yield and therapeutic implications of 25 years of specialized pediatric Marfan clinicRyan E Accord, Chris Koster, Eelco Dulfer, et al.
BMC Pediatrics|December 8, 2020
Hypoxic/ischemic hits predispose to necrotizing enterocolitis in (near) term infants with congenital heart disease: a case control studyMartin van der Heide, Mirthe J Mebius, Arend F Bos, et al.
American Heart Journal|September 26, 2007
Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?Rosa Laura E van Loon, Elke S Hoendermis, Marielle G J Duffels, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Applicability of bosentan in Dutch patients with Eisenmenger syndrome: preliminary results on safety and exercise capacityM G J Duffels, R M F Berger, P Bresser, et al.
Circulation. Cardiovascular Imaging|January 2, 2015
Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcomeMark-Jan Ploegstra, Marcus T R Roofthooft, Johannes M Douwes, et al.
Journal of the American Heart Association|May 9, 2020
GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan CirculationSophie L Meyer, Djoeke Wolff, Floris-Jan S Ridderbos, et al.
Pageof 28

Showing results (151-160 of 277) with videos related to

Sort By:
Pageof 28
Cardiology in the Young|December 21, 2016
Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registryTilman Humpl, Rolf M F Berger, Eric D Austin, et al.
Pulmonary Circulation|July 14, 2022
Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activationEmmanouil Mavrogiannis, Quint A J Hagdorn, Venetia Bazioti, et al.
Pharmacogenomics|June 23, 2017
Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics studyAizati N A Daud, Jorieke E H Bergman, Wilhelmina S Kerstjens-Frederikse, et al.
European Journal of Pediatrics|January 12, 2022
Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER studyAnouk Pels, Wes Onland, Rolf M F Berger, et al.
European Journal of Pediatrics|November 18, 2024
Diagnostic yield and therapeutic implications of 25 years of specialized pediatric Marfan clinicRyan E Accord, Chris Koster, Eelco Dulfer, et al.
BMC Pediatrics|December 8, 2020
Hypoxic/ischemic hits predispose to necrotizing enterocolitis in (near) term infants with congenital heart disease: a case control studyMartin van der Heide, Mirthe J Mebius, Arend F Bos, et al.
American Heart Journal|September 26, 2007
Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?Rosa Laura E van Loon, Elke S Hoendermis, Marielle G J Duffels, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Applicability of bosentan in Dutch patients with Eisenmenger syndrome: preliminary results on safety and exercise capacityM G J Duffels, R M F Berger, P Bresser, et al.
Circulation. Cardiovascular Imaging|January 2, 2015
Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcomeMark-Jan Ploegstra, Marcus T R Roofthooft, Johannes M Douwes, et al.
Journal of the American Heart Association|May 9, 2020
GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan CirculationSophie L Meyer, Djoeke Wolff, Floris-Jan S Ridderbos, et al.
Pageof 28